Most skincare is developed far from the people who use it. INBAR+co grew up in a treatment room. The Living Formulation System is our spa-born, practice-based approach: formulas start as treatment concepts, are tested on real skin under defined protocols, and refined through practitioner-logged observations over weeks and months.
We call this quasi-clinical: structured and documented, without pretending to be a full clinical trial. Small-batch production lets us adjust texture, tolerance, and performance based on what we observe in practice — not just what's on paper. When we update a formula, it's because the observations told us to. Not because of a trend.
"We don't reformulate for trends. We reformulate for results — driven by how skin responds in practice, documented, deliberate, and always communicated."
Is the Living Formulation System the same as a clinical trial?
No. It is practice-based, quasi-clinical observation in spa settings. Structured, logged, and taken seriously — but it is not a formal clinical trial.
How does it benefit me as a client?
he product you're using has already been through real-world testing on a variety of skin types and lived conditions — and it will continue to evolve if we find a better way to serve your skin.
Do you change your formulas over time?
Yes, occasionally — and always for a reason. If we update a formula, it's because our ongoing observations and data suggest it will improve tolerance, performance, or skin longevity.
How is this different from trend-based reformulation?
We don't reformulate for trends; we reformulate for results. Changes are driven by how skin responds in practice, not by ingredient fads.
The Living Formulation System — how it works
| Formulas begin as spa treatment concepts | Active |
| Tested on real skin — practitioner-logged observations |
Active |
| Small-batch production — allows mid-cycle refinement |
Active |
| Reformulation driven by results, never by ingredient trends | Policy |
| Quasi-clinical — structured, documented, not a formal trial | Disclosed |

